Moderna’s final analysis of our Phase 3 COVE Study is out (median follow-up 5.3 months):

•Against COVID-19: 93.2%
•Against severe COVID-19: 98.2%
•Against death caused by COVID-19: 100%

— Chise 🧬🧫🦠💉 (@sailorrooscout) August 5, 2021

Very nice. Immunity seems to persist well. Delta boosters also make sense, though the vaccine is still quite effective even against that variant. I always expected boosters to be required.